Table 2.
Outcomes of patients at baseline, 6 and 12 months (primary outcome: MANSA at 6 months)
| Intervention | Control | Coefficient (95% CI)* | p-value | |||
|---|---|---|---|---|---|---|
| n | mean (SD) | n | mean (SD) | |||
| MANSA | ||||||
| Baseline | 33 | 4.4 ± 0.6 | 32 | 4.3 ± 0.6 | … | … |
| 6 months | 29 | 5.1 ± 0.8 | 26 | 4.3 ± 1.0 | −0.50 (−0.94 − −0.07) | 0.024 |
| 12 months | 26 | 5.7 ± 0.7 | 24 | 3.9 ± 1.2 | −1.52 (−2.37 − −0.67) | 0.001 |
| SIX | ||||||
| Baseline | 33 | 3.9 ± 1.2 | 32 | 4.1 ± 1.3 | … | … |
| 6 months | 29 | 4.2 ± 1.2 | 26 | 4.2 ± 1.5 | 1.48 (−0.13–3.08) | 0.072 |
| 12 months | 26 | 4.8 ± 1.3 | 24 | 3.6 ± 1.4 | 2.20 (0.50–3.90) | 0.011 |
| BPRS | ||||||
| Baseline | 33 | 33.8 ± 7.1 | 32 | 35.6 ± 7.1 | … | … |
| 6 months | 29 | 29.6 ± 3.7 | 26 | 36.8 ± 9.8 | 5.29 (1.94–8.64) | 0.003 |
| 12 months | 26 | 30.7 ± 4.5 | 24 | 37.7 ± 5.5 | 6.85 (3.02–10.67) | 0.001 |
*For the MANSA and BPRS, regression coefficients derived from mixed linear models with a fixed effect for treatment adjusted for baseline scores. For the SIX, proportional odds models with a random intercept and fixed effect for treatment.